AXOGEN INC (AXGN) Fundamental Analysis & Valuation

NASDAQ:AXGN • US05463X1063

Current stock price

39.25 USD
+1.84 (+4.92%)
At close:
39.35 USD
+0.1 (+0.25%)
After Hours:

This AXGN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. AXGN Profitability Analysis

1.1 Basic Checks

  • AXGN had positive earnings in the past year.
  • In the past year AXGN had a positive cash flow from operations.
  • In the past 5 years AXGN always reported negative net income.
  • In multiple years AXGN reported negative operating cash flow during the last 5 years.
AXGN Yearly Net Income VS EBIT VS OCF VS FCFAXGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M -30M -40M

1.2 Ratios

  • AXGN has a Return On Assets of -7.08%. This is in the better half of the industry: AXGN outperforms 66.31% of its industry peers.
  • The Return On Equity of AXGN (-12.19%) is better than 66.31% of its industry peers.
Industry RankSector Rank
ROA -7.08%
ROE -12.19%
ROIC N/A
ROA(3y)-7.67%
ROA(5y)-10.16%
ROE(3y)-14.83%
ROE(5y)-19.41%
ROIC(3y)N/A
ROIC(5y)N/A
AXGN Yearly ROA, ROE, ROICAXGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • Looking at the Gross Margin, with a value of 74.31%, AXGN belongs to the top of the industry, outperforming 83.42% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AXGN has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for AXGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.55%
GM growth 5Y-1.15%
AXGN Yearly Profit, Operating, Gross MarginsAXGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. AXGN Health Analysis

2.1 Basic Checks

  • AXGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AXGN has more shares outstanding than it did 1 year ago.
  • AXGN has more shares outstanding than it did 5 years ago.
  • AXGN has a better debt/assets ratio than last year.
AXGN Yearly Shares OutstandingAXGN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AXGN Yearly Total Debt VS Total AssetsAXGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 12.03 indicates that AXGN is not in any danger for bankruptcy at the moment.
  • AXGN's Altman-Z score of 12.03 is amongst the best of the industry. AXGN outperforms 90.91% of its industry peers.
  • AXGN has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.38, AXGN is in line with its industry, outperforming 45.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 12.03
ROIC/WACCN/A
WACC9.03%
AXGN Yearly LT Debt VS Equity VS FCFAXGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 5.11 indicates that AXGN has no problem at all paying its short term obligations.
  • AXGN has a Current ratio of 5.11. This is in the better half of the industry: AXGN outperforms 75.94% of its industry peers.
  • A Quick Ratio of 3.31 indicates that AXGN has no problem at all paying its short term obligations.
  • AXGN's Quick ratio of 3.31 is fine compared to the rest of the industry. AXGN outperforms 66.31% of its industry peers.
Industry RankSector Rank
Current Ratio 5.11
Quick Ratio 3.31
AXGN Yearly Current Assets VS Current LiabilitesAXGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. AXGN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 123.08% over the past year.
  • The Revenue has grown by 20.21% in the past year. This is a very strong growth!
  • The Revenue has been growing by 14.93% on average over the past years. This is quite good.
EPS 1Y (TTM)123.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)20.21%
Revenue growth 3Y17.56%
Revenue growth 5Y14.93%
Sales Q2Q%21.25%

3.2 Future

  • AXGN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.00% yearly.
  • The Revenue is expected to grow by 18.85% on average over the next years. This is quite good.
EPS Next Y91.69%
EPS Next 2Y69.62%
EPS Next 3Y55.74%
EPS Next 5Y43%
Revenue Next Year18.67%
Revenue Next 2Y17.67%
Revenue Next 3Y17.71%
Revenue Next 5Y18.85%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AXGN Yearly Revenue VS EstimatesAXGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
AXGN Yearly EPS VS EstimatesAXGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. AXGN Valuation Analysis

4.1 Price/Earnings Ratio

  • AXGN is valuated quite expensively with a Price/Earnings ratio of 135.34.
  • Compared to the rest of the industry, the Price/Earnings ratio of AXGN indicates a somewhat cheap valuation: AXGN is cheaper than 65.24% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.47, AXGN is valued quite expensively.
  • AXGN is valuated quite expensively with a Price/Forward Earnings ratio of 70.61.
  • 67.38% of the companies in the same industry are more expensive than AXGN, based on the Price/Forward Earnings ratio.
  • AXGN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.62.
Industry RankSector Rank
PE 135.34
Fwd PE 70.61
AXGN Price Earnings VS Forward Price EarningsAXGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AXGN Per share dataAXGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • AXGN's earnings are expected to grow with 55.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.48
PEG (5Y)N/A
EPS Next 2Y69.62%
EPS Next 3Y55.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AXGN Dividend Analysis

5.1 Amount

  • AXGN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AXGN Fundamentals: All Metrics, Ratios and Statistics

AXOGEN INC

NASDAQ:AXGN (4/24/2026, 4:30:01 PM)

After market: 39.35 +0.1 (+0.25%)

39.25

+1.84 (+4.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-24
Earnings (Next)04-28
Inst Owners83.37%
Inst Owner Change0.76%
Ins Owners1.38%
Ins Owner Change1.4%
Market Cap2.04B
Revenue(TTM)225.21M
Net Income(TTM)-15.70M
Analysts83.75
Price Target41.62 (6.04%)
Short Float %7%
Short Ratio3.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.4%
Min EPS beat(2)-29.35%
Max EPS beat(2)64.15%
EPS beat(4)2
Avg EPS beat(4)-25.5%
Min EPS beat(4)-222.55%
Max EPS beat(4)85.77%
EPS beat(8)6
Avg EPS beat(8)170.95%
EPS beat(12)10
Avg EPS beat(12)136.01%
EPS beat(16)13
Avg EPS beat(16)114.35%
Revenue beat(2)1
Avg Revenue beat(2)1.52%
Min Revenue beat(2)-0.64%
Max Revenue beat(2)3.69%
Revenue beat(4)2
Avg Revenue beat(4)1.76%
Min Revenue beat(4)-1.48%
Max Revenue beat(4)5.47%
Revenue beat(8)4
Avg Revenue beat(8)1.63%
Revenue beat(12)7
Avg Revenue beat(12)0.95%
Revenue beat(16)8
Avg Revenue beat(16)0.5%
PT rev (1m)9.2%
PT rev (3m)12.4%
EPS NQ rev (1m)12.44%
EPS NQ rev (3m)41.38%
EPS NY rev (1m)7.02%
EPS NY rev (3m)12.47%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)0.88%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)2.81%
Valuation
Industry RankSector Rank
PE 135.34
Fwd PE 70.61
P/S 9.05
P/FCF N/A
P/OCF 2508.71
P/B 15.81
P/tB 16.68
EV/EBITDA N/A
EPS(TTM)0.29
EY0.74%
EPS(NY)0.56
Fwd EY1.42%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.02
OCFY0.04%
SpS4.34
BVpS2.48
TBVpS2.35
PEG (NY)1.48
PEG (5Y)N/A
Graham Number4.02479 (-89.75%)
Profitability
Industry RankSector Rank
ROA -7.08%
ROE -12.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.31%
FCFM N/A
ROA(3y)-7.67%
ROA(5y)-10.16%
ROE(3y)-14.83%
ROE(5y)-19.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.55%
GM growth 5Y-1.15%
F-Score5
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 80.2%
Cap/Sales 2.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.11
Quick Ratio 3.31
Altman-Z 12.03
F-Score5
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)159.85%
Cap/Depr(5y)427.53%
Cap/Sales(3y)4.76%
Cap/Sales(5y)10.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)123.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y91.69%
EPS Next 2Y69.62%
EPS Next 3Y55.74%
EPS Next 5Y43%
Revenue 1Y (TTM)20.21%
Revenue growth 3Y17.56%
Revenue growth 5Y14.93%
Sales Q2Q%21.25%
Revenue Next Year18.67%
Revenue Next 2Y17.67%
Revenue Next 3Y17.71%
Revenue Next 5Y18.85%
EBIT growth 1Y-138.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1118.02%
EBIT Next 3Y185.35%
EBIT Next 5Y106.3%
FCF growth 1Y-43572.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.09%
OCF growth 3YN/A
OCF growth 5YN/A

AXOGEN INC / AXGN Fundamental Analysis FAQ

What is the fundamental rating for AXGN stock?

ChartMill assigns a fundamental rating of 4 / 10 to AXGN.


What is the valuation status for AXGN stock?

ChartMill assigns a valuation rating of 2 / 10 to AXOGEN INC (AXGN). This can be considered as Overvalued.


Can you provide the profitability details for AXOGEN INC?

AXOGEN INC (AXGN) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for AXGN stock?

The Price/Earnings (PE) ratio for AXOGEN INC (AXGN) is 135.34 and the Price/Book (PB) ratio is 15.81.


What is the earnings growth outlook for AXOGEN INC?

The Earnings per Share (EPS) of AXOGEN INC (AXGN) is expected to grow by 91.69% in the next year.